BridgeBio Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $15.31 billion, with shareholders equity totaling $-1.65 billion.
The company employs approximately 396 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, BridgeBio Pharma Inc. reported $945.54 million in revenue, generating net income of $-565.83 million.
Key financial metrics include a P/E ratio of -27.06, a price-to-book (P/B) ratio of -9.27, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BBIO.